Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
publishDate:"[2019 TO 2021]"
topic_facet:"COVID-19"
topic_facet:"Recruitment Status: Withdrawn"
journalStr:"ClinicalTrials.gov"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=topic_facet%3A%22COVID-19%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Withdrawn%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=topic_facet%3A%22COVID-19%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Withdrawn%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=topic_facet%3A%22COVID-19%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Withdrawn%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
PubPharm (26)
1
The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations : The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
2
Remotely-conducted Trial of Famotidine vs Placebo for Patients at Home With Coronavirus (COVID) of 2019 (COVID-19) : Proof-of-concept Randomized Placebo-controlled Trial of Famotidine for Outpatients With COVID-19
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
3
Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) : Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
4
Sirolimus in COVID-19 Phase 1 : A Randomized, Double-Blinded, Placebo-Controlled Trial Evaluating the Virological Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sirolimus Adjuvant Therapy in Patients With Coronavirus Disease (COVID-19)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
5
High-Dose Corticosteroid or Tocilizumab for Clinical Worsening of COVID-19 : Comparison of the Treatment Efficacy of High-Dose Corticosteroid and Tocilizumab During Clinical Worsening in Patients With COVID-19 Pneumonia
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
6
A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19 : A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
7
Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection : Repurposing Tazemetostat for the Treatment of Acute Respiratory Distress Syndrome (ARDS) or Systemic Cytokine Release Syndrome (SCRS) in COVID-19 Patient
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
8
'4C' Intervention to Reduce SARS-CoV-2 (Covid-19) Transmission : '4C' Intervention to Reduce SARS-CoV-2 Transmission: Coaching, Cleaning, Communication and Collaboration
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
9
Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19). : A Multicenter, Randomized, Double-blind, Adaptive, Placebo-controlled Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe SARS-CoV-2 Infection (COVID-19)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
10
Antioxidant Therapy for COVID-19 Study : A Study to Evaluate Antioxidant Therapy for Moderate to Severe COVID-19 With or Without Comorbidities
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2019-2021
Filter aufheben
Thema: COVID-19
Filter aufheben
Thema: Recruitment Status: Withdrawn
Filter aufheben
Zeitschrift: ClinicalTrials.gov
Medienart
26
Aufsätze
26
E-Artikel
26
E-Ressourcen
Zeitschriftentitel
ClinicalTrials.gov
Thema
26
610
COVID-19
Recruitment Status: Withdrawn
20
Study Type: Interventional
6
Study Type: Observational
5
Medical Condition: COVID-19
4
Medical Condition: Covid19
4
Phase: Phase 2
4
Phase: Phase 4
3
Phase: Phase 3
3
Severe Acute Respiratory Syndrome
2
Acute Lung Injury
2
Cytokine Release Syndrome
2
Phase: Phase 1
2
Phase: Phase 2, Phase 3
2
Respiratory Distress Syndrome
2
Respiratory Distress Syndrome, Newborn
2
Syndrome
1
Communicable Diseases
1
Coronavirus Infections
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2019-2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
26
Englisch
Haven't found what you're looking for?
Wird geladen...